Oxytocin

Generic Name
Oxytocin
Brand Names
Pitocin
Drug Type
Biotech
Chemical Formula
-
CAS Number
50-56-6
Unique Ingredient Identifier
1JQS135EYN
Background

Sir Henry H. Dale first identified oxytocin and its uterine contractile properties in 1906. Like all other neurohypophysial hormones, oxytocin is composed of nine amino acids with a disulfide bridge between the Cys 1 and 6 residues. In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recog...

Indication

Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern. For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to pre...

Associated Conditions
Incomplete Abortion, Inevitable abortion, Postpartum Bleeding
Associated Therapies
Reinforcement of labor

Induction of Labor With Oxytocin: When Should Oxytocin be Held?

First Posted Date
2009-08-12
Last Posted Date
2019-04-23
Lead Sponsor
Lehigh Valley Hospital
Target Recruit Count
252
Registration Number
NCT00957593
Locations
🇺🇸

Lehigh Valley Health Network, Allentown, Pennsylvania, United States

Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis

First Posted Date
2009-06-12
Last Posted Date
2017-05-23
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
25
Registration Number
NCT00919802
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

A Trial of Oral Misoprostol for Labor Augmentation

Phase 4
Completed
Conditions
Interventions
First Posted Date
2009-05-21
Last Posted Date
2012-11-15
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
350
Registration Number
NCT00906347
Locations
🇺🇸

The University of Texas Southwestern Medical Center, Dallas, Texas, United States

Oxytocin to Decrease Blood Loss During Cesarean Section

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-05-01
Last Posted Date
2013-03-06
Lead Sponsor
American University of Beirut Medical Center
Target Recruit Count
200
Registration Number
NCT00891150
Locations
🇱🇧

American University of Beirut Medical Center, Beirut, Lebanon

Intracervical Catheters for Induction of Labour in Women With Prelabour Rupture of Membranes at Term

First Posted Date
2009-04-30
Last Posted Date
2011-07-20
Lead Sponsor
McMaster University
Target Recruit Count
5
Registration Number
NCT00890630
Locations
🇨🇦

St Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

Oxytocin and Social Cognition in Schizophrenia

First Posted Date
2009-04-21
Last Posted Date
2019-10-02
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
28
Registration Number
NCT00884897
Locations
🇺🇸

Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP), Catonsville, Maryland, United States

Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-11-13
Last Posted Date
2016-04-08
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
1798
Registration Number
NCT00790062
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Cardiac Effects of Oxytocin Administrated During Cesarean Section, Signs of Myocardial Ischemia

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-10-22
Last Posted Date
2014-03-14
Lead Sponsor
Uppsala University
Target Recruit Count
103
Registration Number
NCT00777166
Locations
🇸🇪

University hospital Uppsala, Uppsala, Sweden

The Effect of Oxytocin on the Gastric Emptying

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-10-21
Last Posted Date
2015-04-07
Lead Sponsor
Skane University Hospital
Target Recruit Count
12
Registration Number
NCT00776360

Efficacy and Safety Study of Titrated Oral Misoprostol Solution for Labor Augmentation

Phase 4
Conditions
Interventions
First Posted Date
2008-06-11
Last Posted Date
2008-07-10
Lead Sponsor
China Medical University Hospital
Target Recruit Count
143
Registration Number
NCT00695331
Locations
🇨🇳

Labor Unit, Department of Obstetric and Gynecology, China Medical Univertiy Hospital, Taichung, Taiwan

© Copyright 2024. All Rights Reserved by MedPath